Federal regulators are grappling with a significant backlog of factory inspections for drug manufacturing, with many facilities not reviewed since before the pandemic. An analysis by The Associated ...
WASHINGTON -- Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the covid-19 pandemic upended factory ...
This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.
Nearly 2,000 drug plants have still not been inspected since the COVID-19 pandemic halted global factory checks, an investigation by The Associated Press (AP) found. The AP reported on Thursday that ...
Hosted on MSN
JLR tests drones to speed up factory inspections
Jaguar Land Rover (JLR) has begun testing drone inspections at its Electric Propulsion Manufacturing Centre (EPMC) in Wolverhampton to cut the time needed to check machinery and facilities. According ...
Just as the U.S. hoped to turn the page on COVID-19, the omicron variant touched down, sending case counts to record levels and reigniting debate over social distancing measures. The FDA, which has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback